Amherst researcher Prabhani Atukorale awarded $2.5M for nano-particle based cancer treatment
Amherst researcher Prabhani Atukorale awarded $2.5M for nano-particle based cancer treatment The Cancer Letter
1140 материалов по теме, собраны автоматически из проверенных источников
Amherst researcher Prabhani Atukorale awarded $2.5M for nano-particle based cancer treatment The Cancer Letter
Penn Medicine launches first human clinical trial to test precision form of FLASH proton therapy The Cancer Letter
New framework developed for treating liver cancer by UT Southwestern-led research could lead to updated standards The Cancer Letter
Blood cancer patients may have broader stem cell donor options than previously thought, ACCESS trial shows The Cancer Letter
Alcohol-attributable cancer deaths in the U.S. doubled between 1990 and 2023, Sylvester-led study shows The Cancer Letter
Andrew Hsieh named Larry and Virginia Gordon Endowed Chair in Prostate and Bladder Cancer Research at Fred Hutch The Cancer Letter
Weizhou Zhang named co-leader of expanded immuno-oncology and microenvironment research program at UF Health Cancer Institute The Cancer Letter
Top 10 Cancer Research Grants Open This Fall Oncodaily
Zipalertinib + chemo meets primary endpoint in phase III REZILIENT3 trial in first-line EGFR exon 20 insertion mutation NSCLC The Cancer Letter
Phoebe Ongadi: Shaping an Africa-Led Future for Cancer Research Oncodaily
Shilpa Gupta: Riding to Advance Cancer Research at Cleveland Clinic oncodaily.com
Daniel Flora: Riding 50 Miles for Cancer Research in Cincinnati oncodaily.com
Adelaide University researchers have developed a new way to use mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anticancer immune response.
ESMO Launches €1 Million Clinical Trials Funding Initiative to Support Academic Cancer Research Oncodaily
Mayo Clinic researchers have found that artificial intelligence (AI)-enabled spatial analysis can identify patterns in routine pathology slides that may help clinicians identify which patients with pancreatic cancer are at greater risk of recurrence after treatment and surgery.